Glycated haemoglobin - a marker and predictor of cardiovascular disease

Journal of the Pakistan Medical Association

Volumn 61, Issue 7, 2011, Pages 690-695

  Syed, Iftikhar Ahmad Asim ^a   Khan, Waqar Ahmed ^b  

^a Whitfield Clinics ^*  (Ireland)

^b Whitfield Clinic   (Ireland)

Author keywords

Cardiovascular disease; Glycated haemoglobin; Type 2 diabetes mellitus

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN III; ENDOTHELIN 1; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INTERCELLULAR ADHESION MOLECULE 1; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE HEART INFARCTION; ANKLE BRACHIAL INDEX; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CHRONIC LIVER FAILURE; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; MICROANGIOPATHY; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; PREDICTION; PREVALENCE; PROGNOSIS; REVIEW;

EID: 79959731643     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. ADA Workshop Report; International Expert Committee Report on the Role of the A1C Assay in the diagnosis of Diabetes. Diabetes Care 2009; 32: 1327-1334.
2. ADA Position Statement; Standards of Medical Care in Diabetes - 2010. Diabetes Care 2010; 33(Suppl-1): S11-S61.
3. Sato K K, Hayashi T, Nobuko H, Younda T, Nakamora Y, Endo G, et al, Combined measurement of fasting plasma glucose and A1C is effective for the prediction of type 2 Diabetes; The Kansai Healthcare Study. Diabetes Care 2009; 32: 644-646.
4. Edelman D, Olsen M K, Dudley T K, Harris AC, Oddone E Z. Utility of Hemoglobin A1c in predicting diabetes risk. J Gen Intern Med 2004; 19: 1175-1180.
5. Buse JB, Ginsberg H N, Bakris G L, Clark N G, Costa F, Eckel R, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus. A scientific statement from the American Heart Association and American Diabetes Association. Circulation 2007; 115: 114-126.
6. Kaneto H, Katakami N, Matsuhisa M, Matsouka T. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis, Mediators Inflamm 2010; 2010: 453892.
7. Aronson D, Rayfield EJ. How hyperglycaemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol 2002; 1:1.
8. Cosentino F, Eto M, De Paolis P, Loo B van der, Bachschmid M, Ullrich V, et al High glucose causes upregulation of cyclooxygenase-2 and altered prostanoid profile in human endothelial cells. Role of protein kinase C and reactive oxygen species. Circulation 2003; 107: 1017-1023.
9. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products. Sparking the development of diabetic vascular injury. Circulation 2006; 114: 597-605.
10. Folsom AR, Chambless LE, Duncan BB, Gilbert AC, Pankow JS. Prediction of coronary heart disease in middle-aged adults with diabetes. Diabetes Care 2003; 26: 2777-2784.
11. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laasko M. Mortality from coronary heart diasease in subjects with type 2 diabetes and in nondiabetics subjects with and without prior myocardial infarction. N Eng J Med 1998; 339: 229-234.
12. Turner RC, Millns H, Neil HAW, Straton IM, Mathews DR, Holman RR, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS:23). BMJ 1998; 316: 823-828.
13. Saydah S, Tao M, Imperatore G, Gregg E. GHb Level and subsequent mortality among adults in the U.S. Diabetes Care 2009; 32: 1440-1446.
14. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final report. Circulation 2002; 106: 3143.
15. Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, and Steffes MW. Glycemic control and coronary heart disease risk in persons with and without diabetes, The Atherosclerosis risk in communities study. Arch Intern Med 2005; 165: 1910-1916.
16. Brewer N, Craig SW, Travier N, Cunningham CW, Hornell J, Pearce N, et al. A New Zealand linkage study examining the association between A1c concentration and mortality. Diabetes Care 2008; 31: 1144-1149.
17. Slevin E, Steffes M W, Zhu H, Matsushita K, Wagenknect L, Pankow J, et al, Glycated Haemoglobin, diabetes, and cardiovascular risk in non-diabetic adults. N Eng J Med 2010; 362: 800-811.
18. Park S, Barrett-Connor E, Wingard DL, Shan J, Edelstein S. GHb is a better predictor of cardiovascular disease than fasting or post challenge plasma glucose in women without diabetes. The Rancho Bernardo Study. Diabetes Care 1996; 19: 450-456.
19. Menon V, Greene T, Pereira A A, Wang X, Beck G J, Kusek J W, et al. Glycated haemoglobin and mortality in patients with non-diabetic kidney disease. J Am Soc Nephrol 2005; 16: 3412-3418.
20. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of haemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004; 141: 413-420.
21. Chowdhury TA, Lasker SS. Elevated glycated haemoglobin in non-diabetic patients is associated with an increased mortality in myocardial infarction. Postgrad Med J 1998; 74: 480-481.
22. Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 2001; 322: 1-6.
23. Dilley J, Ganesan A, Deepa R, Deepa M, Sharada G, Williams OD, et al. Association of A1c with cardiovascular disease and metabolic syndrome in Asian Indians with normal glucose tolerance. Diabetes Care 2007; 30: 1527-1532.
24. UKPDS group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
25. Stratton IM, Adler AI, Andrew WN, Mathews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-411.
26. The DCCT Research Group, Effect of Intensive diabetes management on macrovascular events and risk factors in the diabetes control and complication trial. Am J Cardiol 1995; 75: 894-903.
27. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. (DCCT/EDIC) study research group. N Eng J Med 2005; 353: 2643-2653.
28. Gerstein HC, Swedberg K, Carlsson J, Mcmurray JJV, Michelson EL, Olofsson B, et al. The haemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure. Arch Intern Med 2008; 168: 1699-1704.
29. Goode KM, John J, Rigby AS, Kilpatrick ES, Atkin SL, Bragadeesh T, et al. Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus. Heart 2009; 95: 917-923.
30. Iribarren C, Karter AJ, Go AS, Ferrara A, Jennifer Y, Sidney S, et al. Glycemic Control and Heart Failure among adult patients with diabetes. Circulation 2001; 103: 2668-2673.
31. Pazin-Filho A, Kottgen A, Russell SD, Bertoni AG, Slevin E, Rosamond WD, et al. HbA1c as a risk factor for heart failure in persons with diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetologia 2008; 51: 2197-2204.
32. Nicholas GA, Gullion CM, Koro CE, Ephross SA, Brown JB, et al. The Incidence of Congestive Heart failure in type 2 diabetes. Diabetes Care 2004; 27: 1879-1884.
33. Jorgensen L, Jensen T, Joakimsen O, Heuch I, Ingebretsen OC, Jacobson BJ, et al. Glycated haemoglobin level is strongly related to the prevalence of carotid artery plaques with high echogenicity in nondiabetic individuals, The Tromso Study, Circulation 2004; 110: 466-470.
34. Myint PK, Sinha S, Wareham NJ, Bingham S, Luben RN, Welch AA, et al. Glycated haemoglobin and risk of stroke in people without knowndiabetes in European prospective investigation into cancer (EPIC) -Norfolk prospective population study, A threshold relationship? Stroke 2007; 38: 271-275.
35. Ray KK, Seshasai SRK, Wijesuriya S, Sivakuumaran R, Nethercott S, Preiss D, et al. Effect of intensive control of glucose on cardiovascular out comes and death in patients with diabetes mellitus: a meta-analysis of randomized controlled trials. Lancet 2009; 373: 1765-72.
36. Selvin E, Coresh J, Wattanakit K, Steffes MW, Sharrett R. HbA1c and Peripheral arterial disease in diabetes, The ARIC Study. Diabetes Care 2006; 29: 877-82.